Trial Profile
Acupil Non Interventional Study For Evaluation Of Safety Effectiveness And Tolerability.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Quinapril (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Acronyms ASSET
- Sponsors Pfizer
- 19 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 08 Jun 2010 Planned end date changed from Mar 2011 to Jun 2010 as reported by ClinicalTrials.gov.